Follow the IMPACT Therapeutics, Inc - B - H Shares stock price and the full directors' dealings record of the company, a publicly traded company based in Hong Kong. Shares are quoted on HK HK, under the authority of HKEX. The latest transaction was reported on 18 June 2026 (Other). Among the most active insiders: LIU Tao. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
8 of 8 declarations
IMPACT Therapeutics, Inc - B - H Shares is a company focused on developing innovative cancer treatments. It specializes in the research and commercialization of targeted therapies.